APO Research
Talk to an analyst

APO RESEARCH · REPORT

Travelers Vaccines

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Selected research

Market Analysis & Forecast

Global Travelers Vaccines Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchTravelers Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Travelers Vaccines Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Travelers Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Travelers Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Travelers Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Read the full market overview

Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.

This report presents an overview of global market for Travelers Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Travelers Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Travelers Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Travelers Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Travelers Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Travelers Vaccines sales, projected growth trends, production technology, application and end-user industry.

Travelers Vaccines Segment by Company

GlaxoSmithKline

Sanofi Pasteur

Merck

Pfizer

CNBG

Sanofi Pasteur MSD

Serum Institute of India

Biokangtai

Travelers Vaccines Segment by Type

Meningococcal Vaccine

Japanese Encephalitis Vaccine

Yellow Fever Vaccine

Hepatitis Vaccine

Cholera Vaccine

Other

Travelers Vaccines Segment by End Users

Tourists

Students

Workers

Others

Travelers Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Travelers Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Travelers Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Travelers Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Travelers Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Travelers Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Travelers Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Meningococcal Vaccine Major Manufacturers Table 3. Japanese Encephalitis Vaccine Major Manufacturers Table 4. Yellow Fever Vaccine Major Manufacturers Table 5. Hepatitis Vaccine Major Manufacturers Table 6. Cholera Vaccine Major Manufacturers Table 7. Other Major Manufacturers Table 8. Global Travelers Vaccines Market Size Growth Rate by End Users (US$ Million), 2021 VS 2025 VS 2032 Table 9. Tourists Major Manufacturers Table 10. Students Major Manufacturers Table 11. Workers Major Manufacturers Table 12. Others Major Manufacturers Table 13. Travelers Vaccines Industry Trends Table 14. Travelers Vaccines Industry Drivers Table 15. Travelers Vaccines Industry Opportunities and Challenges Table 16. Travelers Vaccines Industry Restraints Table 17. Global Travelers Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Travelers Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Travelers Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Travelers Vaccines Revenue Market Share by Region (2021-2026) Table 21. Global Travelers Vaccines Revenue Market Share by Region (2027-2032) Table 22. Global Travelers Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k doses) Table 23. Global Travelers Vaccines Sales by Region (2021-2026) & (k doses) Table 24. Global Travelers Vaccines Sales by Region (2027-2032) & (k doses) Table 25. Global Travelers Vaccines Sales Market Share by Region (2021-2026) Table 26. Global Travelers Vaccines Sales Market Share by Region (2027-2032) Table 27. Global Travelers Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Travelers Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Travelers Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Travelers Vaccines Sales Market Share by Manufacturers (2021-2026) Table 31. Global Travelers Vaccines Sales Price (USD/dose) of Manufacturers (2021-2026) Table 32. Global Travelers Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Travelers Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Travelers Vaccines Manufacturers, Product Type & Application Table 35. Global Travelers Vaccines Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Travelers Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Travelers Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Travelers Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Travelers Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Travelers Vaccines Revenue Market Share by Type (2021-2026) Table 42. Global Travelers Vaccines Revenue Market Share by Type (2027-2032) Table 43. Global Travelers Vaccines Sales by Type 2021 VS 2025 VS 2032 (k doses) Table 44. Global Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 45. Global Travelers Vaccines Sales by Type (2027-2032) & (k doses) Table 46. Global Travelers Vaccines Sales Market Share by Type (2021-2026) Table 47. Global Travelers Vaccines Sales Market Share by Type (2027-2032) Table 48. Global Travelers Vaccines Price by Type (2021-2026) & (USD/dose) Table 49. Global Travelers Vaccines Price by Type (2027-2032) & (USD/dose) Table 50. Global Travelers Vaccines Revenue by End Users 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Travelers Vaccines Revenue by End Users (2021-2026) & (US$ Million) Table 52. Global Travelers Vaccines Revenue by End Users (2027-2032) & (US$ Million) Table 53. Global Travelers Vaccines Revenue Market Share by End Users (2021-2026) Table 54. Global Travelers Vaccines Revenue Market Share by End Users (2027-2032) Table 55. Global Travelers Vaccines Sales by End Users 2021 VS 2025 VS 2032 (k doses) Table 56. Global Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 57. Global Travelers Vaccines Sales by End Users (2027-2032) & (k doses) Table 58. Global Travelers Vaccines Sales Market Share by End Users (2021-2026) Table 59. Global Travelers Vaccines Sales Market Share by End Users (2027-2032) Table 60. Global Travelers Vaccines Price by End Users (2021-2026) & (USD/dose) Table 61. Global Travelers Vaccines Price by End Users (2027-2032) & (USD/dose) Table 62. GlaxoSmithKline Company Information Table 63. GlaxoSmithKline Business Overview Table 64. GlaxoSmithKline Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 65. GlaxoSmithKline Travelers Vaccines Product Portfolio Table 66. GlaxoSmithKline Recent Development Table 67. Sanofi Pasteur Company Information Table 68. Sanofi Pasteur Business Overview Table 69. Sanofi Pasteur Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 70. Sanofi Pasteur Travelers Vaccines Product Portfolio Table 71. Sanofi Pasteur Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 75. Merck Travelers Vaccines Product Portfolio Table 76. Merck Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 80. Pfizer Travelers Vaccines Product Portfolio Table 81. Pfizer Recent Development Table 82. CNBG Company Information Table 83. CNBG Business Overview Table 84. CNBG Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 85. CNBG Travelers Vaccines Product Portfolio Table 86. CNBG Recent Development Table 87. Sanofi Pasteur MSD Company Information Table 88. Sanofi Pasteur MSD Business Overview Table 89. Sanofi Pasteur MSD Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 90. Sanofi Pasteur MSD Travelers Vaccines Product Portfolio Table 91. Sanofi Pasteur MSD Recent Development Table 92. Serum Institute of India Company Information Table 93. Serum Institute of India Business Overview Table 94. Serum Institute of India Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 95. Serum Institute of India Travelers Vaccines Product Portfolio Table 96. Serum Institute of India Recent Development Table 97. Biokangtai Company Information Table 98. Biokangtai Business Overview Table 99. Biokangtai Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 100. Biokangtai Travelers Vaccines Product Portfolio Table 101. Biokangtai Recent Development Table 102. North America Travelers Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Travelers Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 105. North America Travelers Vaccines Sales by Type (2027-2032) & (k doses) Table 106. North America Travelers Vaccines Sales Price by Type (2021-2026) & (USD/dose) Table 107. North America Travelers Vaccines Sales Price by Type (2027-2032) & (USD/dose) Table 108. North America Travelers Vaccines Revenue by End Users (2021-2026) & (US$ Million) Table 109. North America Travelers Vaccines Revenue by End Users (2027-2032) & (US$ Million) Table 110. North America Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 111. North America Travelers Vaccines Sales by End Users (2027-2032) & (k doses) Table 112. North America Travelers Vaccines Sales Price by End Users (2021-2026) & (USD/dose) Table 113. North America Travelers Vaccines Sales Price by End Users (2027-2032) & (USD/dose) Table 114. North America Travelers Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Travelers Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Travelers Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Travelers Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k doses) Table 118. North America Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 119. North America Travelers Vaccines Sales by Country (2027-2032) & (k doses) Table 120. North America Travelers Vaccines Sales Price by Country (2021-2026) & (USD/dose) Table 121. North America Travelers Vaccines Sales Price by Country (2027-2032) & (USD/dose) Table 122. United States Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 123. Canada Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 124. Mexico Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 125. Europe Travelers Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Travelers Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 128. Europe Travelers Vaccines Sales by Type (2027-2032) & (k doses) Table 129. Europe Travelers Vaccines Sales Price by Type (2021-2026) & (USD/dose) Table 130. Europe Travelers Vaccines Sales Price by Type (2027-2032) & (USD/dose) Table 131. Europe Travelers Vaccines Revenue by End Users (2021-2026) & (US$ Million) Table 132. Europe Travelers Vaccines Revenue by End Users (2027-2032) & (US$ Million) Table 133. Europe Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 134. Europe Travelers Vaccines Sales by End Users (2027-2032) & (k doses) Table 135. Europe Travelers Vaccines Sales Price by End Users (2021-2026) & (USD/dose) Table 136. Europe Travelers Vaccines Sales Price by End Users (2027-2032) & (USD/dose) Table 137. Europe Travelers Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Travelers Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Europe Travelers Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Europe Travelers Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k doses) Table 141. Europe Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 142. Europe Travelers Vaccines Sales by Country (2027-2032) & (k doses) Table 143. Europe Travelers Vaccines Sales Price by Country (2021-2026) & (USD/dose) Table 144. Europe Travelers Vaccines Sales Price by Country (2027-2032) & (USD/dose) Table 145. Germany Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 146. France Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 147. U.K. Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 148. Italy Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 149. Russia Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 150. Spain Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 151. Netherlands Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 152. Switzerland Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 153. Sweden Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 154. Poland Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 155. China Travelers Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 156. China Travelers Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 157. China Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 158. China Travelers Vaccines Sales by Type (2027-2032) & (k doses) Table 159. China Travelers Vaccines Sales Price by Type (2021-2026) & (USD/dose) Table 160. China Travelers Vaccines Sales Price by Type (2027-2032) & (USD/dose) Table 161. China Travelers Vaccines Revenue by End Users (2021-2026) & (US$ Million) Table 162. China Travelers Vaccines Revenue by End Users (2027-2032) & (US$ Million) Table 163. China Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 164. China Travelers Vaccines Sales by End Users (2027-2032) & (k doses) Table 165. China Travelers Vaccines Sales Price by End Users (2021-2026) & (USD/dose) Table 166. China Travelers Vaccines Sales Price by End Users (2027-2032) & (USD/dose) Table 167. Asia Travelers Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Travelers Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 170. Asia Travelers Vaccines Sales by Type (2027-2032) & (k doses) Table 171. Asia Travelers Vaccines Sales Price by Type (2021-2026) & (USD/dose) Table 172. Asia Travelers Vaccines Sales Price by Type (2027-2032) & (USD/dose) Table 173. Asia Travelers Vaccines Revenue by End Users (2021-2026) & (US$ Million) Table 174. Asia Travelers Vaccines Revenue by End Users (2027-2032) & (US$ Million) Table 175. Asia Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 176. Asia Travelers Vaccines Sales by End Users (2027-2032) & (k doses) Table 177. Asia Travelers Vaccines Sales Price by End Users (2021-2026) & (USD/dose) Table 178. Asia Travelers Vaccines Sales Price by End Users (2027-2032) & (USD/dose) Table 179. Asia Travelers Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Travelers Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Travelers Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Travelers Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k doses) Table 183. Asia Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 184. Asia Travelers Vaccines Sales by Country (2027-2032) & (k doses) Table 185. Asia Travelers Vaccines Sales Price by Country (2021-2026) & (USD/dose) Table 186. Asia Travelers Vaccines Sales Price by Country (2027-2032) & (USD/dose) Table 187. Japan Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 188. South Korea Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 189. India Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 190. Australia Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 191. Taiwan Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Travelers Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Travelers Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 196. SAMEA Travelers Vaccines Sales by Type (2027-2032) & (k doses) Table 197. SAMEA Travelers Vaccines Sales Price by Type (2021-2026) & (USD/dose) Table 198. SAMEA Travelers Vaccines Sales Price by Type (2027-2032) & (USD/dose) Table 199. SAMEA Travelers Vaccines Revenue by End Users (2021-2026) & (US$ Million) Table 200. SAMEA Travelers Vaccines Revenue by End Users (2027-2032) & (US$ Million) Table 201. SAMEA Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 202. SAMEA Travelers Vaccines Sales by End Users (2027-2032) & (k doses) Table 203. SAMEA Travelers Vaccines Sales Price by End Users (2021-2026) & (USD/dose) Table 204. SAMEA Travelers Vaccines Sales Price by End Users (2027-2032) & (USD/dose) Table 205. SAMEA Travelers Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Travelers Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Travelers Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Travelers Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k doses) Table 209. SAMEA Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 210. SAMEA Travelers Vaccines Sales by Country (2027-2032) & (k doses) Table 211. SAMEA Travelers Vaccines Sales Price by Country (2021-2026) & (USD/dose) Table 212. SAMEA Travelers Vaccines Sales Price by Country (2027-2032) & (USD/dose) Table 213. Brazil Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 214. Argentina Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 215. Chile Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 216. Colombia Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 217. Peru Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 219. Israel Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 220. UAE Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 221. Turkey Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 222. Iran Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 223. Egypt Travelers Vaccines Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Travelers Vaccines Distributors List Table 227. Travelers Vaccines Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Travelers Vaccines Image Figure 2. Global Travelers Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Travelers Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Meningococcal Vaccine Image Figure 5. Japanese Encephalitis Vaccine Image Figure 6. Yellow Fever Vaccine Image Figure 7. Hepatitis Vaccine Image Figure 8. Cholera Vaccine Image Figure 9. Other Image Figure 10. Global Travelers Vaccines Market Size Growth Rate by End Users (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Travelers Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 12. Tourists Image Figure 13. Students Image Figure 14. Workers Image Figure 15. Others Image Figure 16. Global Travelers Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Travelers Vaccines Revenue (2021-2032) & (US$ Million) Figure 18. Global Travelers Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Travelers Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Travelers Vaccines Revenue Market Share by Region (2021-2032) Figure 21. Global Travelers Vaccines Sales (2021-2032) & (k doses) Figure 22. Global Travelers Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k doses) Figure 23. Global Travelers Vaccines Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Travelers Vaccines Sales YoY (2021-2032) & (k doses) Figure 25. Europe Travelers Vaccines Sales YoY (2021-2032) & (k doses) Figure 26. China Travelers Vaccines Sales YoY (2021-2032) & (k doses) Figure 27. Asia (Excluding China) Travelers Vaccines Sales YoY (2021-2032) & (k doses) Figure 28. South America, Middle East and Africa Travelers Vaccines Sales YoY (2021-2032) & (k doses) Figure 29. Global Travelers Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Travelers Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Travelers Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Travelers Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Travelers Vaccines Revenue Market Share by Type (2021-2032) Figure 35. Global Travelers Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k doses) Figure 36. Global Travelers Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Travelers Vaccines Sales Market Share by Type (2021-2032) Figure 38. Global Travelers Vaccines Revenue by End Users (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Travelers Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Travelers Vaccines Revenue Market Share by End Users (2021-2032) Figure 41. Global Travelers Vaccines Sales by End Users (2021 VS 2025 VS 2032) & (k doses) Figure 42. Global Travelers Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Travelers Vaccines Sales Market Share by End Users (2021-2032) Figure 44. North America Travelers Vaccines Revenue Share by Type (2021-2032) Figure 45. North America Travelers Vaccines Sales Share by Type (2021-2032) Figure 46. North America Travelers Vaccines Revenue Share by End Users (2021-2032) Figure 47. North America Travelers Vaccines Sales Share by End Users (2021-2032) Figure 48. North America Travelers Vaccines Revenue Share by Country (2021-2032) Figure 49. North America Travelers Vaccines Sales Share by Country (2021-2032) Figure 50. Europe Travelers Vaccines Revenue Share by Type (2021-2032) Figure 51. Europe Travelers Vaccines Sales Share by Type (2021-2032) Figure 52. Europe Travelers Vaccines Revenue Share by End Users (2021-2032) Figure 53. Europe Travelers Vaccines Sales Share by End Users (2021-2032) Figure 54. Europe Travelers Vaccines Revenue Share by Country (2021-2032) Figure 55. Europe Travelers Vaccines Sales Share by Country (2021-2032) Figure 56. China Travelers Vaccines Revenue Share by Type (2021-2032) Figure 57. China Travelers Vaccines Sales Share by Type (2021-2032) Figure 58. China Travelers Vaccines Revenue Share by End Users (2021-2032) Figure 59. China Travelers Vaccines Sales Share by End Users (2021-2032) Figure 60. Asia Travelers Vaccines Revenue Share by Type (2021-2032) Figure 61. Asia Travelers Vaccines Sales Share by Type (2021-2032) Figure 62. Asia Travelers Vaccines Revenue Share by End Users (2021-2032) Figure 63. Asia Travelers Vaccines Sales Share by End Users (2021-2032) Figure 64. Asia Travelers Vaccines Revenue Share by Country (2021-2032) Figure 65. Asia Travelers Vaccines Sales Share by Country (2021-2032) Figure 66. SAMEA Travelers Vaccines Revenue Share by Type (2021-2032) Figure 67. SAMEA Travelers Vaccines Sales Share by Type (2021-2032) Figure 68. SAMEA Travelers Vaccines Revenue Share by End Users (2021-2032) Figure 69. SAMEA Travelers Vaccines Sales Share by End Users (2021-2032) Figure 70. SAMEA Travelers Vaccines Revenue Share by Country (2021-2032) Figure 71. SAMEA Travelers Vaccines Sales Share by Country (2021-2032) Figure 72. Travelers Vaccines Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Travelers Vaccines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Yellow Fever Vaccine
  • Hepatitis Vaccine
  • Cholera Vaccine
  • Other
Applications
  • Tourists
  • Students
  • Workers
  • Others
Companies covered
  • GlaxoSmithKline
  • Sanofi Pasteur
  • Merck
  • Pfizer
  • CNBG
  • Sanofi Pasteur MSD
  • Serum Institute of India
  • Biokangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Travelers Vaccines Market by Type
  3. 1.2.1 Global Travelers Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Meningococcal Vaccine
  5. 1.2.3 Japanese Encephalitis Vaccine
  6. 1.2.4 Yellow Fever Vaccine
  7. 1.2.5 Hepatitis Vaccine
  8. 1.2.6 Cholera Vaccine
  9. 1.2.7 Other
  10. 1.3 Travelers Vaccines Market by End Users
  11. 1.3.1 Global Travelers Vaccines Market Size by End Users, 2021 VS 2025 VS 2032
  12. 1.3.2 Tourists
  13. 1.3.3 Students
  14. 1.3.4 Workers
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Travelers Vaccines Market Dynamics
  1. 2.1 Travelers Vaccines Industry Trends
  2. 2.2 Travelers Vaccines Industry Drivers
  3. 2.3 Travelers Vaccines Industry Opportunities and Challenges
  4. 2.4 Travelers Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Travelers Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Travelers Vaccines Revenue by Region
  3. 3.2.1 Global Travelers Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Travelers Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Travelers Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Travelers Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Travelers Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Travelers Vaccines Sales by Region
  9. 3.4.1 Global Travelers Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Travelers Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Travelers Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Travelers Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Travelers Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Travelers Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Travelers Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Travelers Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Travelers Vaccines Sales by Manufacturers
  6. 4.2.1 Global Travelers Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Travelers Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Travelers Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Travelers Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Travelers Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Travelers Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Travelers Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Travelers Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Travelers Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Travelers Vaccines Tier 1, Tier 2, and Tier 3
5 Travelers Vaccines Market by Type
  1. 5.1 Global Travelers Vaccines Revenue by Type
  2. 5.1.1 Global Travelers Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Travelers Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Travelers Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Travelers Vaccines Sales by Type
  6. 5.2.1 Global Travelers Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Travelers Vaccines Sales by Type (2021-2032) & (k doses)
  8. 5.2.3 Global Travelers Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Travelers Vaccines Price by Type
6 Travelers Vaccines Market by Application
  1. 6.1 Global Travelers Vaccines Revenue by Application
  2. 6.1.1 Global Travelers Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Travelers Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Travelers Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Travelers Vaccines Sales by Application
  6. 6.2.1 Global Travelers Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Travelers Vaccines Sales by Application (2021-2032) & (k doses)
  8. 6.2.3 Global Travelers Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Travelers Vaccines Price by Application
7 Company Profiles
  1. 7.1 GlaxoSmithKline
  2. 7.1.1 GlaxoSmithKline Company Information
  3. 7.1.2 GlaxoSmithKline Business Overview
  4. 7.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
  6. 7.1.5 GlaxoSmithKline Recent Developments
  7. 7.2 Sanofi Pasteur
  8. 7.2.1 Sanofi Pasteur Company Information
  9. 7.2.2 Sanofi Pasteur Business Overview
  10. 7.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
  12. 7.2.5 Sanofi Pasteur Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Travelers Vaccines Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Travelers Vaccines Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 CNBG
  26. 7.5.1 CNBG Company Information
  27. 7.5.2 CNBG Business Overview
  28. 7.5.3 CNBG Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CNBG Travelers Vaccines Product Portfolio
  30. 7.5.5 CNBG Recent Developments
  31. 7.6 Sanofi Pasteur MSD
  32. 7.6.1 Sanofi Pasteur MSD Company Information
  33. 7.6.2 Sanofi Pasteur MSD Business Overview
  34. 7.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
  36. 7.6.5 Sanofi Pasteur MSD Recent Developments
  37. 7.7 Serum Institute of India
  38. 7.7.1 Serum Institute of India Company Information
  39. 7.7.2 Serum Institute of India Business Overview
  40. 7.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Serum Institute of India Travelers Vaccines Product Portfolio
  42. 7.7.5 Serum Institute of India Recent Developments
  43. 7.8 Biokangtai
  44. 7.8.1 Biokangtai Company Information
  45. 7.8.2 Biokangtai Business Overview
  46. 7.8.3 Biokangtai Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biokangtai Travelers Vaccines Product Portfolio
  48. 7.8.5 Biokangtai Recent Developments
8 North America
  1. 8.1 North America Travelers Vaccines Market Size by Type
  2. 8.1.1 North America Travelers Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Travelers Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Travelers Vaccines Price by Type (2021-2032)
  5. 8.2 North America Travelers Vaccines Market Size by End Users
  6. 8.2.1 North America Travelers Vaccines Revenue by End Users (2021-2032)
  7. 8.2.2 North America Travelers Vaccines Sales by End Users (2021-2032)
  8. 8.2.3 North America Travelers Vaccines Price by End Users (2021-2032)
  9. 8.3 North America Travelers Vaccines Market Size by Country
  10. 8.3.1 North America Travelers Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Travelers Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Travelers Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Travelers Vaccines Market Size by Type
  2. 9.1.1 Europe Travelers Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Travelers Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Travelers Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Travelers Vaccines Market Size by End Users
  6. 9.2.1 Europe Travelers Vaccines Revenue by End Users (2021-2032)
  7. 9.2.2 Europe Travelers Vaccines Sales by End Users (2021-2032)
  8. 9.2.3 Europe Travelers Vaccines Price by End Users (2021-2032)
  9. 9.3 Europe Travelers Vaccines Market Size by Country
  10. 9.3.1 Europe Travelers Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Travelers Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Travelers Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Travelers Vaccines Market Size by Type
  2. 10.1.1 China Travelers Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Travelers Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Travelers Vaccines Price by Type (2021-2032)
  5. 10.2 China Travelers Vaccines Market Size by End Users
  6. 10.2.1 China Travelers Vaccines Revenue by End Users (2021-2032)
  7. 10.2.2 China Travelers Vaccines Sales by End Users (2021-2032)
  8. 10.2.3 China Travelers Vaccines Price by End Users (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Travelers Vaccines Market Size by Type
  2. 11.1.1 Asia Travelers Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Travelers Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Travelers Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Travelers Vaccines Market Size by End Users
  6. 11.2.1 Asia Travelers Vaccines Revenue by End Users (2021-2032)
  7. 11.2.2 Asia Travelers Vaccines Sales by End Users (2021-2032)
  8. 11.2.3 Asia Travelers Vaccines Price by End Users (2021-2032)
  9. 11.3 Asia Travelers Vaccines Market Size by Country
  10. 11.3.1 Asia Travelers Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Travelers Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Travelers Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Travelers Vaccines Market Size by Type
  2. 12.1.1 SAMEA Travelers Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Travelers Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Travelers Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Travelers Vaccines Market Size by End Users
  6. 12.2.1 SAMEA Travelers Vaccines Revenue by End Users (2021-2032)
  7. 12.2.2 SAMEA Travelers Vaccines Sales by End Users (2021-2032)
  8. 12.2.3 SAMEA Travelers Vaccines Price by End Users (2021-2032)
  9. 12.3 SAMEA Travelers Vaccines Market Size by Country
  10. 12.3.1 SAMEA Travelers Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Travelers Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Travelers Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Travelers Vaccines Value Chain Analysis
  2. 13.1.1 Travelers Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Travelers Vaccines Production Mode & Process
  6. 13.2 Travelers Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Travelers Vaccines Distributors
  9. 13.2.3 Travelers Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst